No insurance? No problem! Shed weight easily with this affordable Ozempic alternative that WORKS: 'I am so happy with my results!'
How many times have you attempted to lose weight only to be thrown off track? Modern science has made it easier for almost anyone to shed unwanted pounds, but unfortunately weight loss drugs are not always accessible.
You can finally take control of your efforts with Hers, the company that offers affordable Ozempic alternatives for a fraction of the price of the name brand. Even better? You don't need insurance — and your weight loss plan is completely personalized to your unique situation.
Hers Weight Loss
It's never too late to get started on your journey to a fitter and healthier you.
If you want to shed pounds, a weight loss solution from Hers could help. The company offers affordable Ozempic alternatives without the need for insurance — and no high costs.
Ready to go? Click through to fill out a brief questionnaire. If approved, a licensed medical provider will prescribe a personalized program featuring either an oral medication kit or compounded GLP-1 medications featuring the same active ingredient as Ozempic.
Feel your best every time you look in the mirror! Hers takes a personalized approach to weight loss with its program that's carefully tailored to your specific health journey and goals
That's absolutely huge, as too many programs simply don't take into account important factors like your health history, your specific goals, and your limitations.
Hers puts you in the driver's seat, beginning with a comprehensive (but easy to complete!) questionnaire that goes over everything from your habits to what types of results you hope to achieve.
The entire process is incredibly streamlined from start to finish, and waiting for you at the end is a weight loss solution from Hers.
If you're prescribed, you'll receive a personalized program featuring either an oral medication kit or compounded GLP-1 injections featuring the same active ingredient found in Ozempic.
Throughout your journey with Hers, you'll have access to regular check-ins with a licensed medical provider. Everything is handled online, making it easy for you to stay connected and on top of your treatment from anywhere.
The app makes everything simple. It's clean and intuitive, with options to track your eating, check in with your provider, keep track of your medications, monitor your weight, and even get advice on everything from exercising to healthy eating.
It's one of the key factors that sets Hers apart from the rest. The program is sleek and holistic, allowing you to feel more in tune with your body during every phase of your path to improved health.
No matter how much weight you may want to lose, you'll feel truly motivated — and that's especially true as you begin to see that number on the scale drop.
Hers uses the same active ingredient found in Ozempic, but without the hassle of dealing with long wait times, insurance, and sky-high costs
Clients have high praise for the program, raving about everything from the quality of care to their incredible results.
'I wanted to lose weight because of health concerns,' shared one Hers user. 'I felt listened to, and the provider took my concerns seriously. Losing 70 pounds has been life-changing!'
Another said, 'The provider I worked with through Hers was responsive and answered all my questions. My eating habits have completely changed!'
'While my doctor was in favor of prescribing Ozempic to me, it wasn't covered by insurance,' wrote a third. 'Thanks to Hers, I could access treatment. I am so happy with my results!'
Why wait to put your health first? Nothing matters more — and if you're ready to change your life and see a real difference, Hers can help you get there.
*DISCLAIMER: Not available in all 50 states. Hers Weight Loss is a holistic program that includes nutrition support, technological tools, and custom medication kits or a compounded GLP-1 prescribed based on what your provider determines is medically appropriate and necessary for you. Hers Weight Loss includes compounded products which are not approved or verified for safety or effectiveness by FDA. See website for full details, important safety information, and restrictions, including online provider consultation requirements.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
20 minutes ago
- Daily Mail
The hospitals with the LONGEST waiting lists revealed: As 7.37million people wait for routine treatment, the Government is slammed for 'misleading' public on NHS figures
The number of people in England waiting for routine hospital treatment has surged for the first time since March. More than 7.37million treatments—relating to 6.23million patients— are now in the queue for ops like hip replacements, official data revealed today. This includes over 190,000 people stuck in limbo for at least a year, often in pain. While the figure for June marks a drop on the record 7.77million treatments logged in September 2023, it is up almost 10,000 on May. Separate NHS monthly performance data today also revealed around 1,000 patients faced waits of at least 12 hours in A&E every day in June. Experts slammed the 'unacceptable' toll being heaped on patients, warning that A&E clinicians are 'reporting this week as one of the worst they have experienced'. It comes just hours after a leading think tank warned the NHS and the Government had 'misled' the public about the reasons why the waiting list has fallen. Health Secretary Wes Streeting has repeatedly claimed the 260,000 drop in the NHS backlog since the general election 'was not a coincidence', adding that it was because of 'record investment and fundamental NHS reform'. But a new Quality Watch report by the Nuffield Trust think tank found 245,000 appointments were being removed every month because patients died, had treatment elsewhere or moved abroad, rather than because treatment had finished. According to the monthly NHS figures, the number of hospital treatments on the waiting list jumped by 9,712 to 7.37million. Some 191,814—2.6 per cent of those in the backlog — had been waiting at least 12 months. And 1,103 had been waiting for at least 18 months. Although that figure is down from the 1,237 in May. Waiting lists last increased in March before falling for two consecutive months. Responding to the latest figures, Dr Becks Fisher, Nuffield Trust director of research and policy, said the waiting list 'remains stubbornly high'. She added: 'Our new analysis shows that waiting list reductions in previous months are not wholly due to increases in appointments being delivered. In fact, the NHS is still treating fewer patients than are being referred. 'But, an average of about 245,000 cases have been coming off the list each month due to reasons other than patients being recorded as getting their treatment. 'Doing this work to improve the accuracy of the waiting list is important, but we should be under no illusions that despite delivering more appointments, the NHS is still not meeting patient demand.' Elsewhere, new analysis from NHS England found more care was delivered during the most recent doctors' strike compared to a year ago. Resident doctors—formerly known as junior doctors—in England took to the picket lines for five days in July 25 in a dispute with the Government over pay. But, according to the health service, 11,071 more appointments and procedures went ahead during this strike compared to the five-day walkout before the general election in 2024. Staff absences were also lower, it said, with around 1,243 fewer staff absent each day on average compared to last June. Health Secretary Wes Streeting said the figures show the NHS 'was more resilient against last month's strike action than ever before'. 'We are getting on with the job of delivering progress in the face of strike action, and we will continue to put patients first,' he said. Latest A&E figures, however, show 35,467 patients had to wait more than 12 hours last month before being admitted, transferred or discharged. Some 76.4 per cent of patients were seen within four hours in A&Es in July, up from 75.5 per cent in June. The health service's target is 78 per cent. But these figures only look at trolley waits — the time between doctors deciding a patient needs to be admitted and them getting a bed. Figures capturing exact arrival times at A&E paint a much bleaker picture, with 122,852 patients (8.3 per cent) forced to wait at least 12 hours. Dr Nick Murch, president of the Society for Acute Medicine, said: 'These figures again highlight the extent of the crisis across urgent and emergency care, with an unacceptable amount of people waiting over 12 hours in emergency departments, often suffering avoidable harm. 'Clinicians across the UK are reporting this week as one of the worst they have experienced, with no sign of the brief respite seen in the immediate aftermath of recent strike action. 'Yet there remains no tangible and immediate action to address urgent workforce and capacity issues. 'Sadly, instead, recent commentary and reporting suggests a growing reliance on selective or misleading interpretations of NHS data, as highlighted this week in analysis by the Nuffield Trust which calls into question claims the NHS is being turned around. 'This is similar to what is being seen in many urgent and emergency care settings where some areas are being rebranded to 'off the clock' areas improving performance data but not changing the patient journey or experience. Cancer patients also faced longer waits in June—separate NHS figures released today show just one of the three national cancer targets were met. Just 67.1 per cent of newly-diagnosed cancer patients referred for urgent treatment were seen within two months—the target is 85 per cent. Meanwhile, only 91.7 per cent of patients started treatment within 31 days of being booked in June, below the goal of 96 per cent. The health service target of telling at least 75 per cent of patients with suspected cancer they do or don't have the disease was, however, met at 76.8 per cent. But separate ambulance figures for July released by the health service today, found response times had improved. Heart attack and stroke patients in England, known as category two callers, had to wait an average of 28 minutes and 40 seconds for paramedics to arrive on the scene. This is almost a minute quicker than June but ten minutes longer than the 18 minute target. The average category one response time—calls from people with life-threatening illnesses or injuries—was 7 minutes and 56 seconds. This is just 1 second longer than the previous month. The target time is seven minutes. Ambulance teams handled more than 843,535 incidents in July.
Reuters
20 minutes ago
- Reuters
Eli Lilly to hike UK price of Mounjaro weight-loss, diabetes medicines by 170%
LONDON, Aug 14 (Reuters) - Eli Lilly (LLY.N), opens new tab will raise the list price in the UK of its weight-loss and type 2 diabetes treatment Mounjaro by 170% to be in line with other European markets, the U.S. drugmaker said on Thursday. Lilly's Mounjaro launched in the UK in February last year, while rival Novo Nordisk's Wegovy treatment has been available in the country since September 2023. The new price is effective from September. Lilly said that the price for a month's supply of highest dose of the medicine will increase from $122 to £330, a 170% increase. In the UK, mirroring dynamics elsewhere, especially in the United States, Lilly challenged Novo's first-mover advantage swiftly after launching. By late 2024, Mounjaro sales outstripped those of Wegovy in the booming online pharmacy market for the medicines, Reuters reported at the time. Lilly said in a statement that when it launched Mounjaro in Britain, it agreed to a list price "significantly below" that in its three other European markets to prevent delays in availability of the medicine through Britain's National Health Service (NHS).
The Independent
an hour ago
- The Independent
Several people treated following chemical spill at Guy's Hospital
A chemical spill at a major London hospital has left one person injured, with several more treated for the inhalation of chlorine gas. Four of the nine patients were taken to hospital by ambulance crews following the incident, which took place in a non-patient area of Guy's Hospital in Southwark. A spokesperson for the hospital urged patients to attend their appointments unless they are told otherwise. Around 150 people were evacuated from the basement and ground floor of Guy's on Thursday morning. Fire and ambulance crews were called a little before 9am following reports of a chemical incident. The chlorine gas is believed to have been produced by the mixing of chemicals inside a plant room. Even small amounts of chlorine gas can lead to irritation in the eyes, throat and lungs, while exposure to high levels can be fatal. One member of staff was injured as a result of the incident, while several people – who came to the aid of the individual – have been treated for chlorine gas inhalation. A London Ambulance Service spokesperson said: 'We sent resources to the scene, including ambulance crews, an incident response officer, a paramedic in a fast response car, an emergency planning officer and paramedics from our hazardous area response team. 'We treated nine people at the scene. We took four patients to hospital and discharged the other five patients at the scene.' A statement from London Fire Brigade said: Firefighters have carried out a sweep of the area to check for no elevated readings of chlorine gas. 'The building has also been ventilated. Crews also supported with the precautionary evacuation of the basement and ground floors of the building.' Guy's is a major elective centre with 400 beds, specialising in cancer, kidney, urology and dental care, as well as ear, nose and throat and orthopaedics. A spokesperson for Guy's and St Thomas's said on Thursday: 'The London Fire Brigade attended a chemical incident in a non-patient area of Guy's Hospital today. 'One staff member was injured and several people, who came to the aid of the person, were treated for the inhalation of chlorine gas. 'The site has now reopened and people should attend their appointments unless they are contacted by us directly.'
